Novartis AG
F:NOT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novartis AG
F:NOT
|
CH |
|
3
|
3M Co
SWB:MMM
|
US |
|
W
|
Warner Bros Discovery Inc
XMUN:J5A
|
US |
|
K
|
KeyCorp
XMUN:KEY
|
US |
|
Aspen Pharmacare Holdings Ltd
F:LDZU
|
ZA |
|
Covestro AG
F:1CO1
|
DE |
|
T
|
Travelers Companies Inc
F:PA9
|
US |
|
N
|
Novartis AG
SWB:NOT
|
CH |
|
Novartis AG
SIX:NOVNEE
|
CH |
Wall St Price Targets
NOT Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for NOT is 138.4 EUR with a low forecast of 105.21 EUR and a high forecast of 165.22 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOT's stock price target?
Price Target
138.4
EUR
According to Wall Street analysts, the average 1-year price target for NOT is 138.4 EUR with a low forecast of 105.21 EUR and a high forecast of 165.22 EUR.
What is the Revenue forecast for Novartis AG?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 3 years is 5%.
What is the Gross Profit forecast for Novartis AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 3 years is 9%.
What is the Pre-Tax Income forecast for Novartis AG?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 3 years is 12%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 3 years is 12%.
